Malignant Ovarian Brenner Tumor

specific

A malignant neoplasm that arises from the ovary. It is characterized by the presence of an invasive malignant urothelial-type cellular component and nests of benign urothelial-type cells in a fibrotic stroma. When the neoplasm is confined to the ovary, the prognosis is good.

64

Centers

0

Active Trials

Cancer Funding

Top Centers for Malignant Ovarian Brenner Tumor(64)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
50.8
2
NCI Comprehensive
50.8
3
NCI Comprehensive
50.8
450.8
550.8
6
NCI Comprehensive
50.8
7
NCI Comprehensive
50.8
8
NCI Comprehensive
50.8
9
NCI Comprehensive
50.8
10
NCI Comprehensive
50.8
11
NCI Comprehensive
50.8
1250.8
13
NCI Comprehensive
50.8
14
NCI Comprehensive
50.8
1550.8
1650.8
1750.8
1850.8
19
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
50.8
20
NCI Comprehensive
50.8
21
NCI Comprehensive
50.8
22
NCI Comprehensive
50.8
23
NCI Comprehensive
50.8
24
NCI Comprehensive
50.8
25
NCI Clinical
50.8
2650.8
27
NCI Comprehensive
50.8
28
NCI Comprehensive
50.8
29
NCI Comprehensive
50.8
3050.8
3150.8
32
NCI Comprehensive
50.8
3350.8
34
Cedars-Sinai CancerLos Angeles, CA
50.8
3550.8
3650.8
37
NCI Comprehensive
50.8
3850.8
3950.8
4050.8
41
NCI Comprehensive
50.8
42
NCI Comprehensive
50.8
43
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
50.8
4450.8
4550.8
4650.8
4750.8
48
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
50.8
4950.8
50
NCI Comprehensive
50.8
5150.8
5250.8
5350.8
5450.8
55
NCI Basic_laboratory
50.8
5650.8
5750.8
5850.8
5950.8
6050.8
6150.8
6250.8
6350.8
6450.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →